CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Chen W, Qin L, Wang S, Li M, Shi D, Tian Y, Wang J, Fu L, Li Z, Guo W, Yu W, Yuan Y, Kang T, Huang W, Deng W.
Chen W, et al. Among authors: deng w.
Mol Oncol. 2014 May;8(3):704-16. doi: 10.1016/j.molonc.2014.02.001. Epub 2014 Feb 14.
Mol Oncol. 2014.
PMID: 24618080
Free PMC article.